Header Logo

Connection

Michael Jelinek to Humans

Back to Details
This is a "connection" page, showing publications Michael Jelinek has written about Humans.
Michael Jelinek
Connection Strength
0.664
Humans
  1. Current State and Future Directions of EGFR-Directed Therapy in Head and Neck Cancer. Curr Treat Options Oncol. 2023 06; 24(6):680-692.
    View in: PubMed
    Score: 0.047
  2. A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101. Oral Oncol. 2021 03; 114:105171.
    View in: PubMed
    Score: 0.040
  3. Adjuvant Osimertinib: A New Standard of Care. Oncologist. 2021 04; 26(4):263-265.
    View in: PubMed
    Score: 0.040
  4. Implications of the UK Biobank prognostic study for preventive cardiology. Eur J Prev Cardiol. 2020 07; 27(10):1034-1035.
    View in: PubMed
    Score: 0.037
  5. Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains? J Clin Oncol. 2019 11 01; 37(31):2807-2814.
    View in: PubMed
    Score: 0.036
  6. Identifying Resistance Mechanisms to Osimertinib via Blood Biopsy. Clin Lung Cancer. 2019 11; 20(6):e597-e600.
    View in: PubMed
    Score: 0.036
  7. Implications of Cardio-Respiratory Fitness on the Performance of Exercise Tests. Heart Lung Circ. 2019 Apr; 28(4):e64-e66.
    View in: PubMed
    Score: 0.034
  8. Management of Early Head and Neck Cancer in Elderly Patients. J Oncol Pract. 2018 09; 14(9):541-546.
    View in: PubMed
    Score: 0.034
  9. Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C. Clin Transl Sci. 2018 07; 11(4):420-427.
    View in: PubMed
    Score: 0.033
  10. Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Res. 2017 04; 37(4):1581-1590.
    View in: PubMed
    Score: 0.031
  11. 40 years of cardiac rehabilitation and secondary prevention in post-cardiac ischaemic patients. Are we still in the wilderness? Int J Cardiol. 2015 Jan 20; 179:153-9.
    View in: PubMed
    Score: 0.026
  12. Reversing social disadvantage in secondary prevention of coronary heart disease. Int J Cardiol. 2014 Feb 15; 171(3):346-50.
    View in: PubMed
    Score: 0.025
  13. Screening for depression in coronary heart disease: the perfect Hegelian dialectic? A short commentary on 'Beyond the blues: the need for integrated care pathways'. Eur J Cardiovasc Prev Rehabil. 2011 Apr; 18(2):222-3.
    View in: PubMed
    Score: 0.020
  14. Diagnosis in General Practice . Chest pain. BMJ. 2009 Nov 03; 339:b4117.
    View in: PubMed
    Score: 0.018
  15. The COACH program produces sustained improvements in cardiovascular risk factors and adherence to recommended medications-two years follow-up. Heart Lung Circ. 2009 Dec; 18(6):388-92.
    View in: PubMed
    Score: 0.018
  16. Metamorphosis: the natural history of coronary heart disease. Sudden death is common. Unexpected death is not. Int J Cardiol. 2007 May 16; 118(1):10-3.
    View in: PubMed
    Score: 0.015
  17. A Novel Immobilization Method for the Treatment of Head and Neck Cancer Using 3D Printing. Pract Radiat Oncol. 2024 Jan-Feb; 14(1):20-23.
    View in: PubMed
    Score: 0.012
  18. A nationwide analysis of salvage surgery for laryngeal cancer in the elderly. Head Neck. 2023 11; 45(11):2915-2924.
    View in: PubMed
    Score: 0.012
  19. Impact of Routine Surveillance Imaging on Recurrence in Sinonasal Malignancies. Anticancer Res. 2022 Nov; 42(11):5449-5455.
    View in: PubMed
    Score: 0.011
  20. Presence of CrkI-containing microvesicles in squamous cell carcinomas could have ramifications on tumor biology and cancer therapeutics. Sci Rep. 2022 03 21; 12(1):4803.
    View in: PubMed
    Score: 0.011
  21. A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study. J Thorac Oncol. 2022 01; 17(1):130-140.
    View in: PubMed
    Score: 0.010
  22. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes: a randomized controlled trial. Coron Artery Dis. 2021 Aug 01; 32(5):432-440.
    View in: PubMed
    Score: 0.010
  23. Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice. Curr Cardiol Rev. 2021; 17(5):e160721187934.
    View in: PubMed
    Score: 0.010
  24. Optimising Secondary Prevention and Cardiac Rehabilitation for Atherosclerotic Cardiovascular Disease During the COVID-19 Pandemic: A Position Statement From the Cardiac Society of Australia and New Zealand (CSANZ). Heart Lung Circ. 2020 Jul; 29(7):e99-e104.
    View in: PubMed
    Score: 0.010
  25. Threshold body mass index and sex-specific waist circumference for increased risk of heart failure with preserved ejection fraction. Eur J Prev Cardiol. 2019 10; 26(15):1594-1602.
    View in: PubMed
    Score: 0.009
  26. Age-specific diastolic dysfunction improves prediction of symptomatic heart failure by Stage B heart failure. ESC Heart Fail. 2019 08; 6(4):747-757.
    View in: PubMed
    Score: 0.009
  27. Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort. Eur J Heart Fail. 2019 04; 21(4):449-459.
    View in: PubMed
    Score: 0.009
  28. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018 10 18; 379(16):1509-1518.
    View in: PubMed
    Score: 0.009
  29. Coaching Patients Saves Lives and Money. Am J Med. 2018 04; 131(4):415-421.e1.
    View in: PubMed
    Score: 0.008
  30. Cardiac Society of Australia and New Zealand Position Statement: Coronary Artery Calcium Scoring. Heart Lung Circ. 2017 Dec; 26(12):1239-1251.
    View in: PubMed
    Score: 0.008
  31. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol. BMC Cardiovasc Disord. 2016 09 05; 16(1):170.
    View in: PubMed
    Score: 0.007
  32. Psychosocial interventions for patients with coronary heart disease and depression: A systematic review and meta-analysis. Eur J Cardiovasc Nurs. 2016 08; 15(5):305-16.
    View in: PubMed
    Score: 0.007
  33. 2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia, 2006. Med J Aust. 2011 Apr 18; 194(8):405-9.
    View in: PubMed
    Score: 0.005
  34. A randomised, feasibility trial of a tele-health intervention for acute coronary syndrome patients with depression ('MoodCare'): study protocol. BMC Cardiovasc Disord. 2011 Feb 25; 11:8.
    View in: PubMed
    Score: 0.005
  35. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Med J Aust. 2006 Nov 20; 185(10):549-57.
    View in: PubMed
    Score: 0.004
  36. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med. 2003 Dec 8-22; 163(22):2775-83.
    View in: PubMed
    Score: 0.003
  37. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000. Med J Aust. 2002 Mar 04; 176(5):211-5.
    View in: PubMed
    Score: 0.003
  38. Coaching patients with coronary heart disease to achieve the target cholesterol: a method to bridge the gap between evidence-based medicine and the "real world"--randomized controlled trial. J Clin Epidemiol. 2002 Mar; 55(3):245-52.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.